logo

LPCN

Lipocine·NASDAQ
--
--(--)
--
--(--)

LPCN fundamentals

Lipocine (LPCN) released its earnings on Aug 5, 2025: revenue was 622.85K (YoY +595.42%), beat estimates; EPS was -0.41 (YoY +26.79%), missed estimates.
Revenue / YoY
622.85K
+595.42%
EPS / YoY
-0.41
+26.79%
Report date
Aug 5, 2025
Earnings Call
6:00 AM on Aug 5, 2025
Meeting link.

Earnings

EPS
Revenue

Revenue & Expenses

LPCN has released its 2025 Q4 earnings report, with revenue of 1.15M, reflecting a YoY change of -67.19%, and net profit of -2.37M, showing a YoY change of -232.99%. The Sankey diagram below clearly presents LPCN's revenue sources and cost distribution.

Key Indicators

Lipocine (LPCN) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Lipocine (LPCN)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown

Balance Sheet

Lipocine (LPCN)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown

Cash Flow

Lipocine (LPCN)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown

Revenue Breakdown

Where does Lipocine (LPCN) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:

Dividend

Track Lipocine (LPCN) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield